Celldex Therapeutics
CLDX
#4578
Rank
NZ$3.66 B
Marketcap
NZ$55.07
Share price
7.14%
Change (1 day)
72.06%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2025 (TTM): -NZ$0.5 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are NZ$1.54 Million. a decrease over its 2024 earnings that were of -NZ$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$0.51 Billion47.31%
2024 -NZ$0.35 Billion37.34%
2023 -NZ$0.25 Billion32.63%
2022 -NZ$0.19 Billion54.88%
2021 -NZ$0.13 Billion39.49%
2020 -NZ$86.44 Million-9.08%
2019 -NZ$95.07 Million-28.64%
2018 -NZ$0.14 Billion-30.11%
2017 -NZ$0.2 Billion-17.75%
2016 -NZ$0.24 Billion4.5%
2015 -NZ$0.23 Billion4.09%
2014 -NZ$0.22 Billion51.57%
2013 -NZ$0.15 Billion40.1%
2012 -NZ$0.11 Billion
2010 -NZ$2.18 Million-96.59%
2009 -NZ$63.82 Million
2006 -NZ$39 Million
2004 -NZ$23.69 Million15.75%
2003 -NZ$20.46 Million-18.69%
2002 -NZ$25.17 Million-41.22%
2001 -NZ$42.81 Million59%
2000 -NZ$26.93 Million27.65%
1999 -NZ$21.1 Million53.12%
1998 -NZ$13.78 Million2.6%
1997 -NZ$13.43 Million-33.62%
1996 -NZ$20.23 Million-1.69%
1995 -NZ$20.58 Million22.92%
1994 -NZ$16.74 Million-0%
1993 -NZ$16.74 Million
1991 -NZ$10.29 Million90.32%
1990 -NZ$5.41 Million10.71%
1989 -NZ$4.89 Million833.33%
1988 -NZ$0.53 Million-400%
1987 NZ$0.17 M-125%
1986 -NZ$0.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.77 B-3,646.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.65 B-3,223.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.25 B-3,543.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-NZ$4.9 Million-99.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-NZ$1.38 Billion 175.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$36.02 M-107.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-157.52%๐Ÿ‡บ๐Ÿ‡ธ USA